Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Employee Share Options

2 Apr 2015 10:36

RNS Number : 3086J
Abzena PLC
02 April 2015
 



ABZENA PLC

 

("Abzena", the "Company" or the "Group")

 

Exercise of Employee Share Options

 

 

2 April 2015

 

Cambridge, UK - Abzena plc (AIM: ABZA) announces that 40,000 new ordinary shares of £0.002 each in the Company (the "Ordinary Shares") have been issued and allotted following the exercise of employee share options. The new Ordinary Shares rank pari passu with the Company's existing issued ordinary shares. Application will be made for admission to trading on AIM and it is expected that admission will occur on 10 April 2015.

Following Admission, the Company's enlarged issued share capital will comprise 97,468,858 ordinary shares with voting rights. No shares are held in Treasury. The total number of voting rights in the Company is therefore 97,468,858. This figure of 97,468,858 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For more information, please contact:

 

John Burt (Chief Executive Officer)

Julian Smith (Chief Financial Officer)

Abzena plc

Tel: +44 (0)1223 903498

Email: john.burt@abzena.com or julian.smith@abzena.com

 

Christopher Golden and Bobbie Hilliam

Cenkos Securities (Nominated Adviser and Broker)

Tel: +44 (0)20 7397 8900

 

Mark Swallow, Chris Gardner

Citigate Dewe Rogerson (Corporate and Financial PR)

Tel: +44 (0)20 7638 9571

Email: abzena@citigatedr.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISLIFVASEIFIIE
Date   Source Headline
17th Aug 201810:17 amRNSForm 8.5 (EPT/RI) Abzena
17th Aug 20188:52 amRNSForm 8.3 - ABZENA PLC
17th Aug 20188:19 amRNSForm 8.5 (EPT/RI) - Abzena Plc
16th Aug 20187:19 amRNSUpdate on partial monetisation
16th Aug 20187:16 amRNSRecommended Cash Offer for Abzena plc
8th Aug 20187:00 amRNSFirst ABZENA Inside GMP drug substance released
6th Jul 20183:55 pmRNSBlocklisting update
2nd Jul 20187:00 amRNSAbzena and Telix sign manufacturing agreement
19th Jun 201812:28 pmRNSAnnual Report and Accounts
14th Jun 20187:00 amRNSFunding update
4th Jun 20187:00 amRNSFinal Results
29th May 20189:00 amRNSNotice of full year results
16th Apr 20187:25 amRNSPre-Close Period Trading Update FY2018
9th Apr 20188:25 amRNSTermination of licence agreement
29th Mar 20185:34 pmRNSIssue of Ordinary Shares
5th Mar 20187:00 amRNSPacificGMP Stanford Settlement
23rd Feb 20187:15 amRNSHardman & Co Research: Investing for growth
5th Jan 20187:00 amRNSBusiness update on US and UK facilities
3rd Jan 20186:12 pmRNSBlock Listing Update
12th Dec 20177:00 amRNSHalf year results: Growth strategy progressing
11th Dec 20177:00 amRNSAbzena secures ADC manufacturing services contract
21st Nov 20179:51 amRNSNotice of half year results
8th Nov 20172:28 pmRNSTR-1: Notification of major holdings
24th Oct 20174:15 pmRNSExercise of options
27th Sep 20177:15 amRNSHardman Research: AGM statement fully discounted
19th Sep 20172:25 pmRNSTR-1: Notification of Major Holdings
19th Sep 20177:00 amRNSAppointment of Non-Executive Director
18th Sep 20175:41 pmRNSTR-1: Notification of Major Holdings
14th Sep 201712:46 pmRNSResult of AGM
14th Sep 20177:00 amRNSTrading Update
31st Aug 201712:15 pmRNSHardman Resrch: Accelerating towards profitability
29th Aug 20172:59 pmRNSTR-1: Notification of major holdings
29th Aug 20177:00 amRNSNotification of claim
21st Aug 20171:44 pmRNSHolding(s) in Company
28th Jul 201712:27 pmRNSNotice of AGM
18th Jul 20177:00 amRNSAbzena and Telix sign licence agreement
11th Jul 20177:00 amRNSAbzena and OBI Pharma sign licence agreement
4th Jul 201711:24 amRNSExercise of Options
3rd Jul 20176:11 pmRNSBlock Listing Update
30th Jun 20175:19 pmRNSTR-1: Notification of Major Interest in Shares
19th Jun 20175:18 pmRNSAnnual Report and Accounts
13th Jun 20177:00 amRNSFinal Results
26th May 20175:24 pmRNSTR-1: Notification of Major Interest in Shares
24th May 20177:11 amRNSAbzena notes True North Therapeutics acquisition
16th May 20177:00 amRNSNotice of Full Year Results
3rd May 201712:58 pmEQSEdison issues outlook on Abzena (ABZA)
3rd May 20177:15 amRNSHardman: Acceleration towards profitability
27th Apr 201711:09 amRNSTR-1: Notification of Major Interest in Shares
21st Apr 201711:21 amRNSInnovations invests £2.9m in Abzena placing
21st Apr 201711:20 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.